Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Acute resveratrol supplementation in coronary artery disease: towards patient stratification.

Diaz M, Avila A, Degens H, Coeckelberghs E, Vanhees L, Cornelissen V, Azzawi M.

Scand Cardiovasc J. 2019 Aug 30:1-6. doi: 10.1080/14017431.2019.1657584. [Epub ahead of print]

PMID:
31429599
2.

Differential effects of resveratrol on the dilator responses of femoral arteries, ex vivo.

Diaz M, Parikh V, Ismail S, Maxamed R, Tye E, Austin C, Dew T, Graf BA, Vanhees L, Degens H, Azzawi M.

Nitric Oxide. 2019 Nov 1;92:1-10. doi: 10.1016/j.niox.2019.07.008. Epub 2019 Jul 29.

PMID:
31369814
3.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Sep;14(9):902. doi: 10.1038/s41565-019-0538-3.

PMID:
31358944
4.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, Neves JD, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Aug;14(8):811. doi: 10.1038/s41565-019-0523-x.

PMID:
31289407
5.

On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Jul;14(7):629-635. doi: 10.1038/s41565-019-0496-9. No abstract available. Erratum in: Nat Nanotechnol. 2019 Aug;14(8):811. Nat Nanotechnol. 2019 Sep;14(9):902.

PMID:
31270452
6.

Small diameter helical vascular scaffolds support endothelial cell survival.

Parikh V, Kadiwala J, Hidalgo Bastida A, Holt C, Sanami M, Miraftab M, Shakur R, Azzawi M.

Nanomedicine. 2018 Nov;14(8):2598-2608. doi: 10.1016/j.nano.2018.08.005. Epub 2018 Aug 31.

PMID:
30172863
7.

Home-Based Rehabilitation With Telemonitoring Guidance for Patients With Coronary Artery Disease (Short-Term Results of the TRiCH Study): Randomized Controlled Trial.

Avila A, Claes J, Goetschalckx K, Buys R, Azzawi M, Vanhees L, Cornelissen V.

J Med Internet Res. 2018 Jun 22;20(6):e225. doi: 10.2196/jmir.9943.

8.

Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.

Farooq A, Shukur A, Astley C, Tosheva L, Kelly P, Whitehead D, Azzawi M.

Acta Biomater. 2018 Aug;76:208-216. doi: 10.1016/j.actbio.2018.06.024. Epub 2018 Jun 20.

PMID:
29933106
9.
10.

Advances in biomaterial design and application for medical intervention.

Azzawi M.

Nanomedicine (Lond). 2017 Sep;12(18):2151-2152. doi: 10.2217/nnm-2017-0263. No abstract available.

11.

The effects of resveratrol on aging vessels.

Diaz M, Degens H, Vanhees L, Austin C, Azzawi M.

Exp Gerontol. 2016 Dec 1;85:41-47. doi: 10.1016/j.exger.2016.09.016. Epub 2016 Sep 22. Review.

PMID:
27666185
12.

Nanotechnology for the diagnosis and treatment of diseases.

Azzawi M, Seifalian A, Ahmed W.

Nanomedicine (Lond). 2016 Aug;11(16):2025-7. doi: 10.2217/nnm-2016-8000. No abstract available.

13.

The influence of silica nanoparticles on small mesenteric arterial function.

Shukur A, Whitehead D, Seifalian A, Azzawi M.

Nanomedicine (Lond). 2016 Aug;11(16):2131-46. doi: 10.2217/nnm-2016-0124. Epub 2016 Aug 2.

PMID:
27480920
14.

An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer.

Karponis D, Azzawi M, Seifalian A.

Nanomedicine (Lond). 2016 Aug;11(16):2215-32. doi: 10.2217/nnm-2016-0113. Epub 2016 Aug 2. Review.

PMID:
27480599
15.

Real-time observation of aortic vessel dilation through delivery of sodium nitroprusside via slow release mesoporous nanoparticles.

Farooq A, Tosheva L, Azzawi M, Whitehead D.

J Colloid Interface Sci. 2016 Sep 15;478:127-35. doi: 10.1016/j.jcis.2016.06.004. Epub 2016 Jun 2.

PMID:
27288578
16.

Investigation of the composition of arterial plaques based on arterial waveforms and material properties.

Feng J, Rajeswaran T, He S, Wilkinson FL, Serracino-Inglott F, Azzawi M, Parikh V, Miraftab M, Alexander MY.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:993-6. doi: 10.1109/EMBC.2015.7318531.

PMID:
26736431
17.

Cross-cultural challenges for assessing medical professionalism among clerkship physicians in a Middle Eastern country (Bahrain): feasibility and psychometric properties of multisource feedback.

Al Ansari A, Al Khalifa K, Al Azzawi M, Al Amer R, Al Sharqi D, Al-Mansoor A, Munshi FM.

Adv Med Educ Pract. 2015 Aug 11;6:509-15. doi: 10.2147/AMEP.S86068. eCollection 2015.

18.

Hereditary deletion of the entire FAM20C gene in a patient with Raine syndrome.

Ababneh FK, AlSwaid A, Youssef T, Al Azzawi M, Crosby A, AlBalwi MA.

Am J Med Genet A. 2013 Dec;161A(12):3155-60. doi: 10.1002/ajmg.a.36160. Epub 2013 Aug 16.

PMID:
24039075
19.

Attenuation of endothelial-dependent vasodilator responses, induced by dye-encapsulated silica nanoparticles, in aortic vessels.

Farooq A, Whitehead D, Azzawi M.

Nanomedicine (Lond). 2014 Mar;9(3):413-25. doi: 10.2217/nnm.12.213. Epub 2013 Feb 22.

PMID:
23432341
20.

Altered sensitivity to nitric oxide donors, induced by intravascular infusion of quantum dots, in murine mesenteric arteries.

Shukur A, Rizvi SB, Whitehead D, Seifalian A, Azzawi M.

Nanomedicine. 2013 May;9(4):532-9. doi: 10.1016/j.nano.2012.10.004. Epub 2012 Oct 29.

PMID:
23117044
21.

Biocompatibility of amorphous silica nanoparticles: Size and charge effect on vascular function, in vitro.

Akbar N, Mohamed T, Whitehead D, Azzawi M.

Biotechnol Appl Biochem. 2011 Sep-Oct;58(5):353-62. doi: 10.1002/bab.46. Epub 2011 Sep 22.

PMID:
21995538
22.
23.

Extravascular pressure modulates responses of isolated rat coronary arteries to vasodilator, but not vasoconstrictor, stimuli.

Azzawi M, Austin C.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1151-6. Epub 2005 Oct 21.

24.

The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathy.

Azzawi M, Kan SW, Hillier V, Yonan N, Hutchinson IV, Hasleton PS.

Histopathology. 2005 Mar;46(3):314-9.

PMID:
15720417
25.

Myogenic regulation of isolated small coronary arteries following increases in extravascular pressure.

Azzawi M, Austin C.

Microvasc Res. 2004 Jul;68(1):71-4. No abstract available.

PMID:
15219422
26.

A single nucleotide polymorphism at position --109 of the RANTES proximal promoter.

Azzawi M, Pravica V, Hasleton PS, Hutchinson IV.

Eur J Immunogenet. 2001 Feb;28(1):95-6. No abstract available.

PMID:
11251691
27.

Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients.

Azzawi M, Hasleton PS, Turner DM, Yonan N, Deiraniya AK, Sinnott PJ, Hutchinson IV.

Hum Immunol. 2001 Feb;62(2):140-2.

PMID:
11182223
28.

Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease.

Azzawi M, Hasleton P.

Cardiovasc Res. 1999 Sep;43(4):850-9. Review. No abstract available.

PMID:
10615412
29.

TNF-alpha in acute cardiac transplant rejection.

Azzawi M, Hasleton PS, Hutchinson IV.

Cytokines Cell Mol Ther. 1999 Mar;5(1):41-9. Review.

PMID:
10390078
30.

RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages.

Azzawi M, Hasleton PS, Geraghty PJ, Yonan N, Krysiak P, El-Gammal A, Deiraniya AK, Hutchinson IV.

J Heart Lung Transplant. 1998 Sep;17(9):881-7.

PMID:
9773860
31.

Distribution of myocardial macrophages in the normal human heart.

Azzawi M, Hasleton PS, Kan SW, Hillier VF, Quigley A, Hutchinson IV.

J Anat. 1997 Oct;191 ( Pt 3):417-23.

32.

TNF alpha mRNA and protein in cardiac transplant biopsies: comparison with serum TNF alpha levels.

Azzawi M, Grant SD, Hasleton PS, Yonan N, Campbell CS, Deiraniya AK, Rahman A, Hutchinson IV.

Cardiovasc Res. 1996 Sep;32(3):551-6.

PMID:
8881515
33.

Interleukin-10 in human heart transplantation: an in situ hybridization study. The Manchester Transplant Cytokine Group.

Azzawi M, Hasleton PS, Grant SC, Stewart JP, Hutchinson IV.

J Heart Lung Transplant. 1995 May-Jun;14(3):519-28.

PMID:
7654735
34.

Sequence and embryonic expression of the murine Hox-3.5 gene.

Geada AM, Gaunt SJ, Azzawi M, Shimeld SM, Pearce J, Sharpe PT.

Development. 1992 Oct;116(2):497-506.

35.

T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis.

Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK.

Am Rev Respir Dis. 1992 Jun;145(6):1477-82.

PMID:
1596021
37.

Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, et al.

J Clin Invest. 1991 May;87(5):1541-6.

38.

Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects.

Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, et al.

Int Arch Allergy Appl Immunol. 1991;94(1-4):169-70.

PMID:
1937868
39.

Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB.

Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1407-13.

PMID:
2252260
40.

T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig.

Frew AJ, Moqbel R, Azzawi M, Hartnell A, Barkans J, Jeffery PK, Kay AB, Scheper RJ, Varley J, Church MK, et al.

Am Rev Respir Dis. 1990 Feb;141(2):407-13.

PMID:
2137315
41.

The Anopheline larvae of Iraq, with a report on A. desert spring.

PRINGLE C, TEKRITI A, AZZAWI M, RIYADH H, MURAYATI Y.

Bull Endem Dis (Baghdad). 1960 Jul;3:36-56. No abstract available.

PMID:
13738051
42.

A field comparison of two types of sprayers used in malaria control.

RIYADH H, AZZAWI M.

Bull Endem Dis (Baghdad). 1954 Jul;1(1):81-5. No abstract available.

PMID:
13219440

Supplemental Content

Loading ...
Support Center